Johnson & Johnson Earnings Beat Boosted by Hepatitis Drug - Presented by: The Aol. On Network

Shares of Johnson & Johnson are in focus on Tuesday after the company posted second quarter results which were better than what Wall Street was expecting. Johnson & Johnson says sales around the world were strong. Excluding one time charges, J&J earned $1.66 a share, that's more than 10 cents better than expectations. Revenue for the quarter was $19.5 billion, slightly better than expectations and a 9 percent increase compared to the same period a year ago.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.005 0.20 ▲ 1.23%
AAPL $ 128.95 0.49 ▲ 0.38%
PBR $ 6.3775 0.25 ▼ 3.81%
CSCO $ 30.14 0.63 ▲ 2.13%
JCP $ 7.84 0.66 ▼ 7.76%
ARUN $ 24.5899 0.22 ▼ 0.89%
ARCP $ 9.89 0.08 ▲ 0.82%
SIRI $ 3.955 0.07 ▲ 1.67%

As of 3/2/2015, 03:59 PM
More Most Active